Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis
Top Cited Papers
Open Access
- 7 February 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 149
- https://doi.org/10.3389/fimmu.2020.00149
Abstract
Non-infectious complications in common variable immunodeficiency (CVID) have emerged as a major clinical challenge. Detailed clinical spectrum, organ-specific pathologies and associated sequelae from 623 CVID patients followed in New York since 1974 were analyzed, and recent insights to pathogenesis were reviewed. Non-infectious manifestations were present in 68.1% of patients, and they do not tend to be present in isolation. They include autoimmunity (33.2%), chronic lung disease (30.3%), lymphoid hyperplasia/splenomegaly (20.9%), liver disease (12.7%), granulomas (9.3%), gastrointestinal disease (7.3%), lymphoma (6.7%), and other malignancies (6.4%). In the lungs, interstitial disease and bronchiectasis were the most common findings, with lymphoma at this site being a rare (n = 6), but serious, manifestation. Bronchiectasis was not a prerequisite for the development of interstitial disease. In the liver, granulomas and nodular regenerative hyperplasia were the most common. Gastrointestinal disease may affect any segment of the intestinal tract, with lymphoid infiltrations and villous blunting being the leading histologic findings. With progression of organ-specific diseases, a wide spectrum of associated sequelae was observed. Lymphoma was more common in females (P = 0.036)-all B cell types except in one subject. Solid organ transplantations (liver, n = 5; lung, n = 4; combined lung and heart, n = 2) and hematopoietic stem cell transplantations (for B cell lymphoma, n = 1) have rarely been performed in this cohort, with mixed outcomes. Recent identification of monogenic defects, in similar to 10-30% of various CVID cohorts, has highlighted the molecular pathways that can affect both antibody production and broader immune regulation. In addition, cellular defects in both innate and adaptive immune systems are increasingly recognized in this syndrome.Funding Information
- National Institute of Allergy and Infectious Diseases
This publication has 102 references indexed in Scilit:
- CVID-associated TACI mutations affect autoreactive B cell selection and activationJCI Insight, 2013
- TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotesJournal of Allergy and Clinical Immunology, 2013
- Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and AutoimmunityAmerican Journal of Human Genetics, 2012
- CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremiaJournal of Allergy and Clinical Immunology, 2012
- Efficacy and safety of rituximab in common variable immunodeficiency‐associated immune cytopenias: a retrospective multicentre study on 33 patientsBritish Journal of Haematology, 2011
- CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiencyJCI Insight, 2010
- B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humansProceedings of the National Academy of Sciences of the United States of America, 2009
- Memory B cells in common variable immunodeficiency: Clinical associations and sex differencesClinical Immunology, 2008
- Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes in heterozygotesJournal of Allergy and Clinical Immunology, 2007
- Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammationin vivoClinical and Experimental Immunology, 2007